Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 4,106 | 2,474 | 0 |
| Receivables | 123 | 26 | 0 |
| TOTAL | $6,256 | $2,550 | $0 |
| Non-Current Assets | |||
| Intangibles | 510 | 548 | 0 |
| Other Non-Current Assets | 0 | 0 | 83 |
| TOTAL | $510 | $548 | $83 |
| Total Assets | $6,765 | $3,097 | $83 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 752 | 391 | 57 |
| TOTAL | $924 | $449 | $95 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 134 | 0 |
| TOTAL | $0 | $134 | $0 |
| Total Liabilities | $924 | $583 | $95 |
| Shareholders' Equity | |||
| Common Shares | 15,294 | 3,847 | 0 |
| Retained earnings | -11,136 | -1,370 | -12 |
| Other shareholders' equity | 1,684 | 38 | 0 |
| TOTAL | $5,842 | $2,514 | $-12 |
| Total Liabilities And Equity | $6,765 | $3,097 | $83 |